p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 25404730)

Published in J Biol Chem on November 17, 2014

Authors

Yang Ou1, Shang-Jui Wang1, Le Jiang1, Bin Zheng2, Wei Gu3

Author Affiliations

1: From the Institute for Cancer Genetics and Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, New York 10032 and.
2: the Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129.
3: From the Institute for Cancer Genetics and Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, New York 10032 and wg8@columbia.edu.

Articles cited by this

A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65

TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85

Cancer cell metabolism: Warburg and beyond. Cell (2008) 11.80

Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol (2008) 11.05

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03

The first 30 years of p53: growing ever more complex. Nat Rev Cancer (2009) 8.00

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 6.89

Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A (2010) 4.99

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18

A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc (2012) 3.87

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature (2012) 3.77

The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res (2004) 2.56

Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul (1984) 2.35

Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ (2003) 2.30

Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature (2013) 2.29

The ins and outs of sphingolipid synthesis. Trends Cell Biol (2005) 1.95

Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A (2011) 1.87

L-serine in disease and development. Biochem J (2003) 1.79

p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol (2011) 1.77

ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell (2012) 1.71

Tumour-associated mutant p53 drives the Warburg effect. Nat Commun (2013) 1.52

p53-dependent repression of polo-like kinase-1 (PLK1). Cell Cycle (2010) 1.51

PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res (2011) 1.30

The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci Transl Med (2011) 1.28

Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res (1994) 1.24

Small-molecule inhibitors of the p53-MDM2 interaction. Curr Top Microbiol Immunol (2011) 1.22

The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci (2013) 1.12

Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget (2013) 0.99

Biosynthetic regulation and intracellular transport of phosphatidylserine in mammalian cells. J Biochem (2003) 0.96

Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. Oncogene (2011) 0.96

Reactivation of p53 as therapeutic intervention for malignant melanoma. Curr Opin Oncol (2014) 0.93

Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation. Proc Natl Acad Sci U S A (2014) 0.92

Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer. Int J Gynecol Cancer (2013) 0.87

p53-Dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene. Cell Cycle (2013) 0.84

Contrasting effects of nutlin-3 on TRAIL- and docetaxel-induced apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells. Mol Cancer Ther (2010) 0.81